Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo


Request an Appointment

Cancer Answer Line:

M-F 8 a.m. - 4:30 p.m. ET

Expand Content

Cancer Clinical Trials Results

3952  Collection of Blood and Bone Marrow from Allogeneic Hematopoietic Cell Transplant Recipients and their Related Donors Main Campus  Aplastic Anemia, Bone Cancer, Bone Marrow Failure, Leukemia, Acute Lymphoblastic (ALL) , Leukemia, Acute Myeloid (AML), Leukemia, Chronic Lymphocytic (CLL), Leukemia, Chronic Myeloid (CML), Lymphoma, Lymphoma, Hodgkin, Lymphoma, Non - Hodgkin, Multiple Myeloma, Myelodysplastic Syndrome (MDS)
ECOG 191014-121 A Phase 3 randomized trial of Blinatumomab for newly diagnosed BCR-ABL negative B lineage acute lymphoblastic leukemia in adults Main Campus Phase 3Leukemia, Acute Lymphoblastic (ALL)
JUNO 1915 16-288 A Phase 2, Single-arm, Multicenter Trial to Determine the Efficacy and Safety of JCAR015 in Adult Subjects with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Main Campus Phase 2Leukemia, Acute Lymphoblastic (ALL)
SWOG 131213-1292 S1312 testing the addition of Inotuzumab Ozogamicin to usual chemotherapy in relapsed and refractory acute leukemia Main Campus Phase 1Leukemia, Acute Lymphoblastic (ALL) , Leukemia, Acute Myeloid (AML)
SWOG 1318 15-651 A Phase II Study of Blinatumomab (NSC-765986) and POMP (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) for Patients greater than or equal to 65 Years of Age with Newly Diagnosed Philadelphia-Chromosome Negative (Ph-) Acute Lymphoblastic Leukemia (ALL) and of Dasatinib (NSC-732517), Prednisone and Blinatumomab for Patients greater than or equal 65 Years of Age with Newly Diagnosed Philadelphia-Chromosome Positive (Ph+) ALL. Main Campus  Leukemia, Acute Lymphoblastic (ALL)

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).


Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.